Glaukos
Kali Cottingame has a diverse work experience in scientific and research roles. Kali started their career as a Research Associate II at Integrity Bio in 2008, where they gained experience in protein/peptide formulation development and utilized various analytical techniques. In 2015, they joined Pfizer as a Senior Associate Scientist, focusing on vaccine immunotherapeutics R&D. At Pfizer, they performed routine analysis and in vivo studies on pipeline vaccines. Kali then worked at Quest Diagnostics as a Scientist, where they conducted research and development of mass spectrometry clinical assays. Kali developed LC-MS/MS methods for clinical diagnostics and analyzed results from extracted analytes. In 2018, they joined Medicus Biosciences as a Research Scientist, leading laboratory experiments and conducting stability studies on commercial products. Kali also worked as a Scientific Consultant, and later a Chemist, at RxSight, Inc., supporting R&D experiments and conducting GLP analytical chemical testing. Currently, they are working as a Scientist at Glaukos Corporation.
Kali Cottingame holds a Master's degree in Biotechnology and Bioinformatics, which they earned from California State University Channel Islands in 2013-2014. Prior to that, they obtained a B.A. in Molecular and Cell Biology from the University of California, Berkeley, where they studied from 2003 to 2007. Kali also holds a Certificate in Regulatory Affairs & Compliance, although the specific duration and institution for this qualification are not provided.
This person is not in any teams
Glaukos
3 followers
At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.